DANONE financials
DANONE
Country: FR Reporting currency: EUR Latest annual report: 2024-12-31
LEI:
969500KMUQ2B6CBAF162 Financial statements
(EUR, as reported — unscaled; 115 line items across 2 annual periods)
| Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | €27.38B | €27.62B |
| Cost of sales | €13.77B | €14.54B |
| Operating profit (EBIT) | €3.38B | €2.04B |
| Income tax expense | €929.0M | €768.0M |
| Profit for the year | €2.10B | €953.0M |
| — attributable to owners | €2.02B | €881.0M |
| — attributable to NCI | €79.0M | €72.0M |
| Total comprehensive income | €2.93B | €187.0M |
| Per share | ||
| Basic EPS | €3.14 | €1.36 |
| Diluted EPS | €3.13 | €1.36 |
| Free cash flow / share | €4.33 | €3.70 |
| Cash flow statement | ||
| Net cash from operating activities | €3.83B | €3.44B |
| Net cash from investing activities | -€463.0M | -€834.0M |
| Purchase of PP&E (capex) | €923.0M | €847.0M |
| Net cash from financing activities | -€3.82B | -€2.06B |
| Dividends paid | €1.46B | €1.34B |
| Balance sheet | ||
| Total assets | €45.29B | €44.49B |
| Non-current assets | €32.51B | €31.57B |
| Intangible assets & goodwill | €24.01B | €23.09B |
| Current assets | €12.79B | €12.92B |
| Inventories | €2.28B | €2.34B |
| Trade & other receivables | €2.92B | €2.92B |
| Cash & equivalents | €1.48B | €2.36B |
| Total equity | €17.85B | €16.22B |
| — attributable to owners | €17.80B | €16.18B |
| Non-controlling interests | €59.0M | €46.0M |
| Non-current liabilities | €13.71B | €14.28B |
| Current liabilities | €13.73B | €13.98B |
| Short-term borrowings | €4.63B | €5.53B |
| Deferred tax liabilities | €1.48B | €1.49B |
| Derived metrics | ||
| Free cash flow | €2.91B | €2.60B |
| Operating margin | 12.3% | 7.4% |
| Net margin | 7.7% | 3.5% |
| Return on equity | 11.8% | 5.9% |
| Cash conversion ratio | 1.82× | 3.61× |
| Capex coverage | 4.15× | 4.06× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | €50.0M | €41.0M |
| Adjustments For Decrease Increase In Trade Account Receivable | -€7.0M | €74.0M |
| Adjustments For Deferred Tax Expense | €61.0M | -€46.0M |
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €1.17B | €1.61B |
| Adjustments For Increase Decrease In Trade Account Payable | €353.0M | €324.0M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | -€225.0M | -€7.0M |
| Adjustments For Provisions | -€21.0M | -€52.0M |
| Adjustments For Sharebased Payments | €71.0M | €61.0M |
| Adjustments For Undistributed Profits of Associates | €7.0M | €13.0M |
| Brand Names | €5.39B | €5.26B |
| Cash Flows From Used In Operations Before Changes In Working Capital | €3.30B | €3.17B |
| Comprehensive Income Attributable To Noncontrolling Interests | €89.0M | €69.0M |
| Comprehensive Income Attributable To Owners of Parent | €2.84B | €118.0M |
| Current Derivative Financial Assets | €37.0M | €16.0M |
| Current Derivative Financial Liabilities | €19.0M | €23.0M |
| Current Investments | €4.68B | €3.64B |
| Deferred Tax Assets | €528.0M | €746.0M |
| Dividends Paid To Equity Holders of Parent Classified As Financing Activities | €1.35B | €1.28B |
| Dividends Paid To Noncontrolling Interests Classified As Financing Activities | €108.0M | €62.0M |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | €2.10 | — |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€2.0M | -€503.0M |
| Equity and Liabilities | €45.29B | €44.49B |
| General and Administrative Expense | €2.93B | €2.75B |
| Income Tax Relating To Cash Flow Hedges of Other Comprehensive Income | €6.0M | -€17.0M |
| Income Tax Relating To Investments In Equity Instruments of Other Comprehensive Income | €12.0M | -€2.0M |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | €93.0M | -€35.0M |
| Income Taxes Paid Refund Classified As Operating Activities | €766.0M | €730.0M |
| Increase Decrease In Cash and Cash Equivalents | -€452.0M | €49.0M |
| Increase Decrease In Working Capital | -€534.0M | -€277.0M |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | €36.0M | -€164.0M |
| Increase Decrease Through Sharebased Payment Transactions | €71.0M | €61.0M |
| Increase Decrease Through Transfers and Other Changes Equity | -€43.0M | €170.0M |
| Increase Decrease Through Treasury Share Transactions | €25.0M | €17.0M |
| Interest Expense | €600.0M | €513.0M |
| Interest Revenue Expense | -€197.0M | -€172.0M |
| Investment Accounted For Using Equity Method | €583.0M | €416.0M |
| Issue of Equity | €76.0M | €69.0M |
| Issued Capital | €170.0M | €169.0M |
| Liabilities Included In Disposal Groups Classified As Held For Sale | €0 | €90.0M |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | €0 | €376.0M |
| Noncurrent Derivative Financial Assets | €3.0M | €34.0M |
| Noncurrent Derivative Financial Liabilities | €246.0M | €293.0M |
| Noncurrent Financial Liabilities | €10.18B | €10.74B |
| Noncurrent Provisions For Employee Benefits | €900.0M | €904.0M |
| Other Adjustments For Noncash Items | €122.0M | €669.0M |
| Other Comprehensive Income Before Tax Cash Flow Hedges | €35.0M | -€45.0M |
| Other Comprehensive Income Before Tax Gains Losses From Investments In Equity Instruments | -€12.0M | -€15.0M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | €4.0M | -€118.0M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | €902.0M | -€638.0M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | €931.0M | -€666.0M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | -€114.0M | -€96.0M |
| Other Current Assets | €1.39B | €1.26B |
| Other Current Nonfinancial Liabilities | €3.96B | €3.58B |
| Other Finance Cost | €224.0M | €245.0M |
| Other Finance Income | €41.0M | €60.0M |
| Other Inflows Outflows of Cash Classified As Financing Activities | -€1.01B | -€220.0M |
| Other Inflows Outflows of Cash Classified As Investing Activities | €87.0M | -€17.0M |
| Other Intangible Assets | €556.0M | €498.0M |
| Other Noncurrent Financial Assets | €864.0M | €839.0M |
| Other Operating Income Expense | -€179.0M | -€1.44B |
| Payments From Changes In Ownership Interests In Subsidiaries | €0 | €118.0M |
| Payments To Acquire Or Redeem Entitys Shares | €0 | €0 |
| Proceeds From Contributions of Noncontrolling Interests | -€1.0M | €0 |
| Proceeds From Issue of Bonds Notes and Debentures | €1.40B | €1.60B |
| Proceeds From Issuing Shares | €76.0M | €69.0M |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €18.0M | €15.0M |
| Proceeds From Sales Or Maturity of Financial Instruments Classified As Investing Activities | €507.0M | €177.0M |
| Purchase of Financial Instruments Classified As Investing Activities | €153.0M | €162.0M |
| Repayments of Bonds Notes and Debentures | €2.01B | €1.85B |
| Repayments of Subordinated Liabilities | €0 | €750.0M |
| Research and Development Expense | €447.0M | €398.0M |
| Reserve of Exchange Differences On Translation | -€3.13B | -€4.04B |
| Revenue From Interest | €403.0M | €341.0M |
| Selling Expense | €6.57B | €6.29B |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €30.0M | €36.0M |
| Share Premium | €5.33B | €5.26B |
| Trade and Other Current Payables To Trade Suppliers | €5.15B | €4.78B |
| Treasury Shares | €1.53B | €1.55B |
| Undated Subordinated Liabilities | €500.0M | €500.0M |
Methodology
Every line item above is a fact tagged in DANONE's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.